InsightRX’s Precision Medicine Technology to Help Improve Care for Patients Receiving Stem Cell Transplants

SAN FRANCISCO: SAN FRANCISCO, Nov. 22, 2021 /PRNewswire/ -- InsightRX, which provides a cloud-based precision dosing platform to help guide treatment decisions, today announced that Memorial Sloan Kettering Cancer Center (MSK) has implemented its precision dosing platform to tailor dosing of certain chemotherapy and immunosuppressive drugs used in the administration...

Click to view original post